Pharmacogenetics of SGLT2 Inhibitors

NCT02462421 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped Did not meet recruitment targets.

Conditions

Diabetes Mellitus
Gout
Hyperuricemia

Interventions

DRUG: Canagliflozin

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]